Comparing the Long-Term Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Versus Mineralocorticoid Receptor Antagonists as Add-On Therapies in the Management of Heart Failure: A Systematic Review. [PDF]
CureusGeorge V +5 more
europepmc +1 more source
Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases. [PDF]
ESC Heart FailWang J +4 more
europepmc +1 more source
Different aspects of pharmacological heart failure treatment. [PDF]
Eur Heart J Cardiovasc PharmacotherAgewall S.
europepmc +1 more source
Formulation and Characterization of Eplerenone Nanocrystal as Sublingual Fast-dissolving Film
Hawraa A. Kareem, Nawal Rajab
openalex +2 more sources
Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists. [PDF]
Rev Cardiovasc MedBozkurt B, Januzzi JL, Bansal S.
europepmc +1 more source
Eplerenone, diabetes, and chronic kidney disease in patients hospitalized for acute heart failure: findings from the EARLIER trial. [PDF]
Cardiovasc DiabetolKobayashi M +8 more
europepmc +1 more source
パーシャルアゴニスト カッセイ ヲ ユウスル シンキ MR キッコウヤク ノ ヤクリ サヨウ ニカンスル ケンキュウ コウカリウム ケッショウ リスク テイゲンカ ニ チャクモク シタ シンキ チリョウ センリャク [PDF]
ナリアイ, テツロウ +1 more
core
Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease. [PDF]
Eur Heart JKobayashi M +5 more
europepmc +1 more source
Cardiovascular Outcomes and Hyperkalemia Risk in Patients With Diabetes, Chronic Kidney Disease and Heart Failure: A Real-World Comparison of Non-steroidal versus Steroidal Mineralocorticoid Receptor Antagonists. [PDF]
CureusOkunlola AO +7 more
europepmc +1 more source